Comparing Generic Drug Markets in Europe and the United States: Prices Volumes and Spending

摘要

Policy Points: class="unordered" style="list-style-type:disc" id="milq12279-list-0001">Our study indicates that there are opportunities for cost savings in generic drug markets in Europe and the United States.Regulators should make it easier for generic drugs to reach the market.Regulators and payers should apply measures to stimulate price competition among generic drugmakers and to increase generic drug use.To meaningfully evaluate policy options, it is important to analyze historical context and understand why similar initiatives failed previously.